Stay updated on Rucaparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Rucaparib in Ovarian Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedFallopian tube cancer was added to the Conditions. A new Genetic and Rare Diseases Information Center resource was added under Resources, and the page revision updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check19 days agoChange DetectedA minor version update from Revision: v3.4.0 to v3.4.1 is shown, with no observable changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check20 days agoChange DetectedRevision tag updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check28 days agoChange DetectedGlossary display added; QC metadata updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' with older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' removed and 'Revision: v3.3.4' replaced by 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedThe page revision changed from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check70 days agoChange DetectedThe Locations section was expanded and reorganized to include numerous regional sites across the US, Canada, Australia, and Europe. Some locations were added (e.g., Arizona, California, New South Wales, Île-de-France) and others removed, in the v3.3.3 revision.SummaryDifference2%

Stay in the know with updates to Rucaparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib in Ovarian Cancer Clinical Trial page.